Utilizing miR-34a-Loaded HER2-Targeting Exosomes to Improve Breast Cancer Treatment: Insights From an Animal Model
MiR-34a-loaded HER2-targeting exosomes demonstrate strong anticancer efficacy by selectively binding to HER2-positive breast cancer cells and effectively suppressing PD-L1 expression.
Authors
- Woo Young Sun (ORCID: https://orcid.org/0000-0002-5447-4266)
- Say‐June Kim (ORCID: https://orcid.org/0000-0001-5171-4837)
- Dosang Lee (ORCID: https://orcid.org/0000-0002-1528-2317)
- Ho Joong Choi (ORCID: https://orcid.org/0000-0002-0862-098X)
- Ok‐Hee Kim (ORCID: https://orcid.org/0000-0002-9204-2587)
- Jung Hyun Park
Institutions
- Korea Pharma (South Korea) (KR)
- The Catholic University of Korea Daejeon St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Journal of Breast Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4048/jbc.2024.0262
- Citations
- 6
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 4.84
Funders
- National Research Foundation of Korea